Zai Lab (ZLAB) Change in Acquisitions & Divestments (2019 - 2025)
Zai Lab (ZLAB) posted quarterly Change in Acquisitions & Divestments of $330.0 million for Q1 2025, up 1924.54% year-on-year from $16.3 million in Q1 2024, and up 1924.54% on a QoQ basis from $16.3 million in Q1 2024.
Zai Lab (ZLAB) Change in Acquisitions & Divestments (2019 - 2025) Analysis & Trends
Zai Lab (ZLAB) has reported Change in Acquisitions & Divestments for 7 consecutive years, with $330.0 million the latest figure, recorded in Q1 2025.
- Quarterly Change in Acquisitions & Divestments rose 1924.54% year-over-year to $330.0 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $330.0 million (up 1924.54% YoY) and the FY2025 annual result came in at $330.0 million, up 1924.54% from the prior year.
- Change in Acquisitions & Divestments advanced to $330.0 million in Q1 2025 per ZLAB's latest filing, from $16.3 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for ZLAB reached as high as $743.9 million in Q1 2021 and fell as low as $15.3 million in Q4 2023.
- A 5-year average of $191.3 million and a median of $42.2 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments sank 96.89% — and 2025, when it surged 1924.54%.
- Year by year, Change in Acquisitions & Divestments stood at $743.9 million in 2021, then declined by 22.67% to $575.3 million in 2022, then slumped by 97.34% to $15.3 million in 2023, then climbed by 6.54% to $16.3 million in 2024, then jumped by 1924.54% to $330.0 million in 2025.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $330.0 million, $16.3 million, and $15.3 million for Q1 2025, Q1 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 468.28 Bn | 463.49 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.49 Bn | 115.24 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.26 Bn | 61.51 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - |
| 8 | Argenx Se | 55.67 Bn | 50.48 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn |
| 10 | Zai Lab | 20.77 Bn | 20.02 Bn | 61.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 330.00 Mn |
| Mar 31, 2025 | 330.00 Mn |
| Mar 31, 2024 | 16.30 Mn |
| Mar 31, 2024 | 16.30 Mn |
| Dec 31, 2023 | 15.30 Mn |
| Dec 31, 2023 | 15.30 Mn |
| Sep 30, 2023 | 17.90 Mn |
| Sep 30, 2023 | 17.90 Mn |
| Jun 30, 2023 | 35.05 Mn |
| Jun 30, 2023 | 35.05 Mn |
| Mar 31, 2023 | 49.45 Mn |
| Mar 31, 2023 | 49.45 Mn |
| Sep 30, 2022 | 575.27 Mn |
| Sep 30, 2022 | 575.27 Mn |
| Jun 30, 2022 | 30.00 Mn |
| Jun 30, 2022 | 30.00 Mn |
| Mar 31, 2022 | 100.00 Mn |
| Mar 31, 2022 | 100.00 Mn |
| Mar 31, 2021 | 743.90 Mn |
| Mar 31, 2021 | 743.90 Mn |